Emerging Drugs in Sport

Part I THE EVOLVING DOPING SCENARIO.- The Evolution of Performance-Enhancing Drug Use in Sport.- Contamination of Sports Supplements with Novel Psychoactive Substances: An Old History with New Players!.- Untested Supplement Use Among Athletes: An Overlooked Phenomenon?.- Challenges Posed by Gene Manipulations and Sport Performance.- PART II NAVIGATING IN A DIFFICULT REGULATORY ENVIRONMENT.- The 'Forced' Union of Science and Law.- International Drug Control: Protecting the Health of the Athlete.- Tackling New Forms of Doping: The Legal Challenges.- PART III TOWARDS A DOPING SOCIETY?.- Olympism and the Idea of Anti-doping: Between the Thick and Thin Interpretations of Sporting Progress.- Emerging Trends in Doping: Investigations and Field Operations.- Anti-doping Stories Narrated by a Law Enforcement Investigator - Mind the "Good Guys"!.- The Performance Enhanced: Clinical Relationships Between Performance- and/or Image-Enhancing Drugs, Physical Exercise and Mental Disorders.- "PART IV WINNING AT ANY COST: DOPING EXPERIENCES OF WORLD-CLASS ATHLETES".- Faster and Dirtier for Russia: The Story of Yuliya Stepanova.- Is It Worth Winning a Race if You Lose Yourself in the Process? An Interview with Olympic Champion Tyler Hamilton.- A Hammer Thrower's Journey with Doping: Being the Phoenix of My Own Life.- To Take or Not to Take? Why I Chose to Stay Clean.- PART V TRUTH IN THE TEST TUBES?.- Forensic Analysis of Seized Drugs.- Analysis of New Chemical Entities in a Sport Context.- Hair Testing of Doping Agents: Potential and Limitations.- PART VI THE NEXT CHALLENGE.- What Will the Next Challenges Be? 

Olivier Rabin, PhD is the Senior Executive Director in charge of Science and Medicine at the World Anti-Doping Agency (WADA). Over the years, he has established an international reputation as an expert in pharmaceutical research and development. With a background in fundamental and applied toxicology, he is the author of numerous scientific publications.
Ornella Corazza, PhD is an Associate Professor in Substance Addiction and Behaviours at the University of Hertfordshire in the UK and leading scholar in the field of novel psychoactive substances. Her work has been presented in numerous peer-reviewed publications, books and invited lectures and recognised internationally with various prizes and awards. She is the President of the International Society for the Study of Emerging Drugs (ISSED).